Formulation Development and Evaluation of Floating Microsphere of Acyclovir
The guanine derivative antiviral drug acyclovir (ACV) is one of the oldest molecules laying successful market until date, being commercially available in various dosage forms for oral, topical and parenteral administrations. Clinical application of this drug is superior to new antiviral agents due to its potential values such as suppression of recurrence, safety profile, minimal drug interactions and being inexpensive. ACV is slightly water soluble, less permeable and poorly bioavailable, yet more potential antiviral molecule. The present study involves preparation and evaluation of floating microspheres using ACV as a model drug for improving the drug bioavailability by prolongation of gastric retention time. Ethyl cellulose, hydroxyl propyl methyl cellulose microspheres loaded with ACV were prepared by solvent diffusion evaporation method. The microspheres had smooth surfaces with free-flowing and good-packing properties. The yield of the microspheres (F1-F6) was range from 62.23±0.85 to73.32±0.65% and ethyl cellulose microspheres entrapped the maximum amount of the drug. Scanning electron microscopy confirmed their hollow structures with sizes in 198.3 nm. The prepared microspheres (F3) exhibited prolonged drug release and percentage buoyancy was found to 76.65±0.52. The formulated batches were evaluated for percentage yield, particle size measurement, flow properties, percent entrapment efficiency, swelling studies. The formulations were subjected to stability studies and In-vitro release and release kinetics data was subjected to different dissolution models. It was concluded that developed floating microspheres of ACV offers a suitable and practical approach for prolonged release of drug over an extended period of time and thus oral bioavailability, efficacy and patient compliance is improved.
Keywords: Acyclovir, Solvent diffusion evaporation method, Ethyl cellulose, Hydroxyl propyl methyl cellulose
2. Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm 2010; 74(2): 332-339.
3. Baumgartner S, Kristl J, Vrecer F, Vodopivec P, Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 2000; 195(1-2): 125-135.
4. Bulgarelli E, Forni F, Bernabei MT. Effect of matrix composition and process conditions on casein-gelatin beads floating properties. Int J Pharm 2000; 198(2): 157-165.
5. Davoudi ET, Noordin MI, Kadivar A, Kamalidehghan B, Farjam AS, Javar HA. Preparation and characterization of a gastric floating dosage form of capecitabine. Biomed Res Int 2013; doi: 10.1155/2013/495319.
6. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000; 63(3): 235-259.
7. Garg R, Gupta G. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008; 7(3): 1055-1066.
8. Chen J, Park K. Synthesis of fast-swelling, superporous sucrose hydrogels. Carbohyd Polym 2000; 41(3): 259-268.
9. Shaikh R, Singh TRR, Garland MJ, W oolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci 2011; 3(1): 89-100.
10. Boddupalli BM, Mohammed ZNK, Nath RA, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res 2010; 1(4): 381-387.
11. Kedzierewicz F, Thouvenot P, Lemut J, Etienne A, H offman M, Maincent P. Evaluation of peroral silicone dosage forms in hymans by gamma-scintigraphy. J Control Release 1999; 58(2): 195-205.
12. Rouge N, Allémann E, Gex-Fabry M, Balant L, Cole ET, Buri P, et al. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv 1998; 73(2): 81-87.
13. Prajapati PH, Nakum VV, Patel CN. Formulation and evaluation of floating matrix tablet of stavudine. Int J Pharm Investig 2012; 2(2): 83-89.
14. Chaturvedi K, Umadevi S, Vaghani S. Floating matrix dosage form for propranolol hydrochloride based on gas formation technique: development and in vitro evaluation. Sci Pharm 2010; 78(4): 927-939.
15. Murata Y, Sasaki N, Miyamoto E, Kawashima S. U se of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm 2000; 50(2): 221-226.
16. Jagtap YM, Bhujbal RK, Ranade AN, Ranpise NS. Effect of various polymers concentrations on physicochemical properties of floating microspheres. Indian J Pharm Sci 2012; 74(6): 512-520.
17. Jain AK, Jain CP , Tanwar YS, Naruka PS. Formulation, characterization and in vitro evaluation of floating microspheres of famotidine as a gastro retentive dosage form. Asian J Pharm 2009; 3(3): 222-226.
18. El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm 2001; 220(1-2): 13-21.
19. El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Development of floating microspheres to improve oral bioavailability of cefpodoxime proxetil. Int J Pharma 2001; 220: 13-21.
20. Wakde PH , K asliwal RH , Mane SB. Design and fabrication of gastroretentive bilayer floating tablet of propronolol HCl using natural polymer. Int J Pharm Sci Res 2013; 4(12): 4715-4728.
21. Pandya N, P andya M, Bhaskar VH. Preparation and in vitro characterization of porous carrier-based glipizide floating microspheres for gastric delivery. J Young Pharm 2011; 3(2): 97-104.
22. Jagdale SC, Agavekar AJ, Pandya SV, Kuchekar BS, Chabukswar AR. Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride. AAPS PharmSciTech 2009; 10(3): 1071-1079.
23. Hussain MN, M asum MAA, Akhter S, Sharmin F, Reza MS. Formulation and evaluation of gastro retentive floating tablets of simvastatin using hydrophilic rate retardant. Bangladesh Pharm J 2012; 15(2): 119-126.
24. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother. 1983; 12 Suppl B:29–37.
25. Steingrimsdottir H, Gruber A, Palm C, Grimfors G, Kalin M, Eksborg S. Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy. Antimicrob Agents Chemother. 2000; 44(1):207–9. PMID: 10602752
26. Bras AP, Sitar DS, Aoki FY. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol. 2001; 8 (4):207–11. PMID: 11743593
27. Haznedar S, Dortunc B. Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide. Int J Pharm 2004; 269(1): 131-140.
28. Tanwar Y S, Naruka P S, Ojha G R. Development and evaluation of floating microspheres of verapamil hydrochloride. Brazilian Journal of Pharmaceutical Sciences vol. 43, n. 4, out./dez., 2007, 529-534.
29. Deepa MK, Karthikeyan M. Cefpodoxime Proxetil Floating Microsphere: Formulation and In vitro Evaluation. Iran J Pharm Sci 2009; 5(2):69-72.
30. Brahamankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics e a treatise, pharmacokinetics: basic consideration. 2nd ed. Vallabh Prakashan; 2009. pp. 240e3.
31. Higuchi T. Mechanism of sustained action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52:1145e9.
32. Korsmeyer RW, Gumy R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymer. Int J Pharm 1983; 15:25e35.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).